Group 1 - The core point of the article highlights that Lianhuan Pharmaceutical's shareholder count decreased to 30,095 as of June 30, 2025, representing a reduction of 218 shareholders or 0.72% compared to March 31, 2025 [1][2] - The average shareholding value per shareholder for Lianhuan Pharmaceutical is 95,100 yuan, which is below the industry average of 394,700 yuan for A-share listed companies in the chemical pharmaceutical sector [1][2] - The stock price of Lianhuan Pharmaceutical increased by 2.51% from March 31, 2025, to June 30, 2025, despite the decrease in shareholder count [1][2] Group 2 - From March 31, 2025, to June 30, 2025, the net outflow of main funds for Lianhuan Pharmaceutical was 74.91 million yuan, while retail investors saw a net inflow of 88.67 million yuan [2] - The average number of shares held per shareholder increased from 9,416.96 shares on March 31, 2025, to 9,485.17 shares on June 30, 2025 [2] - The overall trend in shareholder count shows fluctuations, with a notable increase of 3,244 shareholders from December 31, 2024, to March 31, 2025, followed by a decrease in the subsequent quarter [2]
联环药业6月30日股东户数3.01万户,较上期减少0.72%